Autoimmune Pancreatitis.
Am J Gastroenterol
; 113(9): 1301, 2018 09.
Article
em En
| MEDLINE
| ID: mdl-29910463
ABSTRACT
Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pancreatite
/
Imunoglobulina G
/
Icterícia Obstrutiva
/
Doença Relacionada a Imunoglobulina G4
/
Fatores Imunológicos
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article